Wasley J - Search Results

1

CGS 22745: a selective orally active inhibitor of 5-lipoxygenase.

Kimble E, Kowalski T, White D, Raychauduri A, Pastor G, Chertock H, Lee W, Neale R, Hamdan A, Wasley J. Kimble E, et al. Among authors: wasley j. Agents Actions. 1991 Sep;34(1-2):125-8. doi: 10.1007/BF01993256. Agents Actions. 1991. PMID: 1665286

2

Characterization of CGS 8515 as a selective 5-lipoxygenase (5-LO) inhibitor.

Ku EC, Raychaudhuri A, Ghai G, Kimble EF, Lee WH, Colombo C, Dotson R, White D, Oglesby TD, Wasley JW. Ku EC, et al. Among authors: wasley jw. Adv Prostaglandin Thromboxane Leukot Res. 1989;19:86-9. Adv Prostaglandin Thromboxane Leukot Res. 1989. PMID: 2526568

3

Characterization of CGS 8515 as a selective 5-lipoxygenase inhibitor using in vitro and in vivo models.

Ku EC, Raychaudhuri A, Ghai G, Kimble EF, Lee WH, Colombo C, Dotson R, Oglesby TD, Wasley JW. Ku EC, et al. Among authors: wasley jw. Biochim Biophys Acta. 1988 Apr 15;959(3):332-42. doi: 10.1016/0005-2760(88)90207-x. Biochim Biophys Acta. 1988. PMID: 2833314

4

Biochemical and pharmacological characterization of CGS 12066B, a selective serotonin-1B agonist.

Neale RF, Fallon SL, Boyar WC, Wasley JW, Martin LL, Stone GA, Glaeser BS, Sinton CM, Williams M. Neale RF, et al. Among authors: wasley jw. Eur J Pharmacol. 1987 Apr 7;136(1):1-9. doi: 10.1016/0014-2999(87)90772-2. Eur J Pharmacol. 1987. PMID: 3496228

5

Pharmacokinetic screening of o-naphthoquinone 5-lipoxygenase inhibitors.

Rakhit A, Kuwahara SK, Jones DR, Soliman VF, Kotake AN, Oglesby TD, Wasley JW, Tripp SL, Douglas FL. Rakhit A, et al. Among authors: wasley jw. Pharm Res. 1990 Oct;7(10):1071-6. doi: 10.1023/a:1015903519637. Pharm Res. 1990. PMID: 2281039

6

CGS 20625, a novel pyrazolopyridine with selective anxiolytic activity.

Jarvis MF, Bennett DA, Loo PA, Braunwalder AF, Thompson TN, Schmutz M, Yokoyoma N, Wasley JW, Williams M. Jarvis MF, et al. Among authors: wasley jw. Prog Clin Biol Res. 1990;361:477-82. Prog Clin Biol Res. 1990. PMID: 1981266 No abstract available.

7

CGS 20625, a novel pyrazolopyridine anxiolytic.

Williams M, Bennett DA, Loo PS, Braunwalder AF, Amrick CL, Wilson DE, Thompson TN, Schmutz M, Yokoyoma N, Wasley JW. Williams M, et al. Among authors: wasley jw. J Pharmacol Exp Ther. 1989 Jan;248(1):89-96. J Pharmacol Exp Ther. 1989. PMID: 2563294

8

CGS 9343B, a novel, potent, and selective inhibitor of calmodulin activity.

Norman JA, Ansell J, Stone GA, Wennogle LP, Wasley JW. Norman JA, et al. Among authors: wasley jw. Mol Pharmacol. 1987 May;31(5):535-40. Mol Pharmacol. 1987. PMID: 3033469

9

CGS 7525A, a new, centrally active alpha 2 adrenoceptor antagonist.

Liebman JM, Lovell RA, Braunwalder A, Stone G, Bernard P, Barbaz B, Welch J, Kim HS, Wasley JW, Robson RD. Liebman JM, et al. Among authors: wasley jw. Life Sci. 1983 Jan 24;32(4):355-63. doi: 10.1016/0024-3205(83)90081-4. Life Sci. 1983. PMID: 6131367

10

Novel calmodulin antagonist CGS 9343B inhibits secretory diarrhea.

Shook JE, Burks TF, Wasley JW, Norman JA. Shook JE, et al. Among authors: wasley jw. J Pharmacol Exp Ther. 1989 Oct;251(1):247-52. J Pharmacol Exp Ther. 1989. PMID: 2795459

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters